The U.S. Food and Drug Administration (FDA) awarded Dnanexus, Inc. a single-award indefinite delivery contract with a $24 million ceiling value to provide the PrecisionFDA Collaborative Omics Environment in the cloud. This contract supports the FDA's regulatory science initiatives through precision medicine approaches, enabling collaboration between FDA researchers, reviewers, bioinformaticians, and data scientists.
Under this IDV, the FDA has issued multiple delivery orders to Dnanexus for cloud-based bioinformatics tools, genomic data management, and analysis platform services. These services span operations, development, integration, and maintenance of the PrecisionFDA environment, which serves as a FISMA-authorized, secure data repository and analysis platform. The work primarily takes place in Maryland and supports the FDA's efforts to advance regulatory science through the application of multi-omics and artificial intelligence to product development and review processes.
Generated 9/27/24, 9:05 AM